Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Normi Brück

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Dermatologie (Heidelberg, Germany)|January 19, 2024
[Juvenile localized scleroderma]Timmy Strauss, Claudia Günther, Normi Brück
Zeitschrift Fur Rheumatologie|February 17, 2025
[Juvenile idiopathic arthritis-Diagnosis and management]Normi Brück, Christiane Reiser, Prasad Thomas Oommen, et al.
Pediatric Rheumatology Online Journal|September 19, 2023
Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositisTimmy Strauss, Claudia Günther, Anja Schnabel, et al.
Current Rheumatology Reports|April 22, 2018
Therapeutic Approaches to Type I InterferonopathiesMarc Bienias, Normi Brück, Constanze Griep, et al.
European Journal of Rheumatology|December 6, 2019
Orbital inflammation and colitis in pediatric IgG4-related disease: A case report and review of the literatureLissy Tille, Anja Schnabel, Martin W Laass, et al.
Clinical Immunology (Orlando, Fla.)|December 22, 2019
High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysisAnja Schnabel, Elisabeth Unger, Normi Brück, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2022
Course and outcome of chilblain-like acral lesions during COVID-19 pandemicKristin Blau, Sophia Lehr, Roland Aschoff, et al.
Rheumatology (Oxford, England)|November 17, 2020
Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?André Heinen, Anja Schnabel, Normi Brück, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2020
Janus kinase inhibition in complement component 1 deficiencyChristine Wolf, Normi Brück, Sarah Koss, et al.
European Journal of Pediatrics|January 28, 2025
Pediatric eosinophilic fasciitis: similarities and differences with adult formsThibaut César, Diane Giovannini, Alban Deroux, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Dermatologie (Heidelberg, Germany)|January 19, 2024
[Juvenile localized scleroderma]Timmy Strauss, Claudia Günther, Normi Brück
Zeitschrift Fur Rheumatologie|February 17, 2025
[Juvenile idiopathic arthritis-Diagnosis and management]Normi Brück, Christiane Reiser, Prasad Thomas Oommen, et al.
Pediatric Rheumatology Online Journal|September 19, 2023
Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositisTimmy Strauss, Claudia Günther, Anja Schnabel, et al.
Current Rheumatology Reports|April 22, 2018
Therapeutic Approaches to Type I InterferonopathiesMarc Bienias, Normi Brück, Constanze Griep, et al.
European Journal of Rheumatology|December 6, 2019
Orbital inflammation and colitis in pediatric IgG4-related disease: A case report and review of the literatureLissy Tille, Anja Schnabel, Martin W Laass, et al.
Clinical Immunology (Orlando, Fla.)|December 22, 2019
High-dose intravenous methylprednisolone in juvenile non-infectious uveitis: A retrospective analysisAnja Schnabel, Elisabeth Unger, Normi Brück, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2022
Course and outcome of chilblain-like acral lesions during COVID-19 pandemicKristin Blau, Sophia Lehr, Roland Aschoff, et al.
Rheumatology (Oxford, England)|November 17, 2020
Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?André Heinen, Anja Schnabel, Normi Brück, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2020
Janus kinase inhibition in complement component 1 deficiencyChristine Wolf, Normi Brück, Sarah Koss, et al.
European Journal of Pediatrics|January 28, 2025
Pediatric eosinophilic fasciitis: similarities and differences with adult formsThibaut César, Diane Giovannini, Alban Deroux, et al.
Pageof 2